GPX4 and diabetes mellitus: Namely, a significant difference among the experimental groups was noted in GPX4 expression at the tissue level, and post hoc tests revealed that its expression was decreased in diabetes (p < 0.001), while Fer-1 treatment alleviated this effect of DM, although it still remained below the control level (p < 0.001) (Figure 2c).